IRIS
SCALISE, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.126
EU - Europa 3.141
AS - Asia 1.783
SA - Sud America 127
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 10.274
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.086
UA - Ucraina 780
SG - Singapore 683
TR - Turchia 411
IE - Irlanda 409
RU - Federazione Russa 360
DE - Germania 350
SE - Svezia 333
DK - Danimarca 292
HK - Hong Kong 260
CN - Cina 212
IT - Italia 207
FI - Finlandia 180
KR - Corea 160
FR - Francia 126
BR - Brasile 110
CI - Costa d'Avorio 70
GB - Regno Unito 52
IR - Iran 27
CA - Canada 20
MX - Messico 19
MA - Marocco 14
IN - India 13
BE - Belgio 11
NL - Olanda 9
AT - Austria 8
RO - Romania 6
CL - Cile 5
AR - Argentina 4
BD - Bangladesh 4
BG - Bulgaria 4
PL - Polonia 4
EC - Ecuador 3
EU - Europa 3
CM - Camerun 2
CY - Cipro 2
ES - Italia 2
IQ - Iraq 2
OM - Oman 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IS - Islanda 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
VN - Vietnam 1
Totale 10.274
Salva come PNG Salva come JPEG
Città #
Jacksonville 784
Chandler 506
Fairfield 491
Dublin 409
Boardman 370
Singapore 348
Wilmington 287
Hong Kong 252
Ashburn 242
Woodbridge 228
Houston 198
Seattle 189
New York 187
Cambridge 168
Lawrence 157
Princeton 157
San Mateo 156
Ann Arbor 140
Moscow 138
Des Moines 82
Abidjan 70
Turin 60
San Diego 52
Beijing 25
Izmir 23
The Dalles 23
Shanghai 21
Munich 18
Los Angeles 16
Wuhan 15
Guangzhou 14
Mexico City 14
Norwalk 14
London 13
Turku 13
Falls Church 12
Helsinki 12
Redmond 12
Brussels 11
Kilburn 10
Nuremberg 10
Ottawa 10
Centro 8
Buffalo 7
Dallas 6
Jiaxing 6
São Paulo 6
Washington 6
Wuxi 6
Seoul 5
Amsterdam 4
Pesaro 4
Stockholm 4
Venice 4
Andover 3
Belo Horizonte 3
Brasília 3
Brooklyn 3
Campinas 3
Campobasso 3
Chizhou 3
Cingoli 3
Delhi 3
Hangzhou 3
Macerata 3
Milan 3
Montreal 3
North Bergen 3
Palermo 3
Rio de Janeiro 3
San Jose 3
Toronto 3
Acton 2
Americana 2
Arco 2
Asunción 2
Boston 2
Buenos Aires 2
Cava De' Tirreni 2
Caxias do Sul 2
Central 2
Charlotte 2
Contagem 2
Dalian 2
Denver 2
Dhaka 2
Florianópolis 2
Guarulhos 2
Guayaquil 2
Hounslow 2
Las Vegas 2
Marche 2
Maringá 2
Muscat 2
New Delhi 2
Nicosia 2
Olgiate Comasco 2
Phoenix 2
Porto Alegre 2
Pune 2
Totale 6.133
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 269
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 218
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 190
Antimicrobial Resistance: A Challenge for the Future 181
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 147
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 138
Anticryptosporidial activity of paromomycin. 117
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 102
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 91
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 90
Epidemiology and microbiology of surgical wound infections. 89
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 88
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 88
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 86
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 86
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 84
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 84
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 83
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 83
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 82
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 82
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 81
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 80
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 80
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 79
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 79
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 79
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 78
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 77
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 76
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 76
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 76
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 76
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 76
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 75
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 75
In- vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. 75
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 75
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 75
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 74
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 74
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 74
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 74
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 73
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. 72
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 72
LL-37 protects rats against lethal gram-negative sepsis. 71
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 71
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 71
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens 70
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. 70
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 69
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 68
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. 68
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 68
In vitro activities of tachyplesin III against Pseudomonas aeruginosa. 68
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 68
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci. 67
[Prevalence of Toxocara spp in public playgrounds in a town of Central Italy] 67
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 67
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 66
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients. 65
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 65
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. 65
Interactions of posaconazole and flucytosine against Cryptococcus neoformans. 65
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 65
In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii. 64
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 64
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 64
In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides. 64
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 64
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 63
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 63
Potential therapeutic role of cationic peptides in three experimental models of septic shock 62
In-Vitro Activity of Histatins Derivative P-113 Alone and in Combination with Antimicrobial Agents Against Multidrug-Resistant Pathogens Responsible of Pneumonia in Immunocompromised Patients. 62
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 62
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 62
In Vitro Activity of Aurein 1.2 Alone and in Combination with Antibiotics against Gram-positive Nosocomial Cocci 62
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 62
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 61
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 61
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 60
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 60
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 59
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections 59
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 59
Strongyloides stercoralis first-stage larvae in the lungs of a patient with AIDS: primary localization or a noninvasive form of dissemination? 58
Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa. 58
Polycationic peptides as prophylactic agents against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection 58
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 57
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 57
HIV and HBV infection in subjects referred to a dermatological clinic. 57
Therapeutic efficacy of the magainin analog MSI-78 in different intra-abdominal sepsis rat models 56
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 56
Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. 56
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 56
In-vitro effect of short-term exposure to cathelicidin peptides on Cryptosporidium parvum. 55
In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria. 55
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. 55
Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy 54
Totale 7.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.542
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020251 0 0 0 0 0 0 0 0 0 0 19 232
2020/20212.164 115 250 325 42 242 159 216 147 207 166 195 100
2021/20221.154 88 240 0 51 9 106 45 63 73 194 37 248
2022/20231.684 202 170 135 121 124 180 4 82 487 8 128 43
2023/20241.032 212 18 44 190 200 201 15 7 5 5 25 110
2024/20252.077 280 199 177 113 105 150 263 96 469 103 122 0
Totale 10.429